Walpar Nutritions Ltd.
Snapshot View

59.90 -3.10 ▼-4.9%

07 October 2022, 03:31:41 PM
Volume: 2,000

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website
Market Cap 28.61 Cr.
Enterprise Value(EV) 35.40 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 0.84 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 75.15 Trailing Twelve Months Ending 2022-03
Industry PE 32.07 Trailing Twelve Months Ending 2022-03
Book Value / Share 10.00 Trailing Twelve Months Ending 2022-03
Price to Book Value 6.30 Calculated using Price: 63.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.45 Cr. 4,541,220 Shares
FaceValue 10
Company Profile
The company does third party manufacturing of Nutraceutical products on job work basis. The raw material is procured by it for which it receives order for manufacturing their semi-finished/finished Nutraceutical products. It also does marketing of products which are manufactured by it under its own brand. Its products are sold through whole seller distributors/ sales distribution channels. It is also engage in trading of raw material used in manufacturing Nutraceutical products. Such raw material is basically also raw material which is used in manufacturing of its own products.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-4.92%
1 Week
-0.17%
1 Month
-20.13%
3 Month
+76.70%
6 Month
+113.93%
1 Year
+74.38%
2 Year
5 Year
10 Year
2 years 2021-03 2022-03
Return on Equity (%) 3.28 4.58
Return on Capital Employed (%) 2.83 5.00
Return on Assets (%) 0.83 1.55

Balance Sheet View Details >>

Particulars 2 years 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 5 11
Non Curr. Liab. 5 1
Curr. Liab. 9 14
Minority Int. 0 2
Equity & Liab. 18 28
Non Curr. Assets 3 9
Curr. Assets 15 19
Misc. Exp. not W/O 0 0
Total Assets 18 28

Profit Loss View Details >>

Particulars 2 years 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 6 27
Other Income 0
Total Income 6 27
Total Expenditure -6 -26
PBIDT 0 1
Interest 0 0
Depreciation 0 0
Taxation 0 0
Exceptional Items 0
PAT 0 0
Minority Interest 0
Share Associate
Other Related Items
Consolidated Net Profit 0 0
Adjusted EPS 0 1

Cash Flow View Details >>

Particulars 2 years 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 -1
Cash Fr. Inv. -2 -6
Cash Fr. Finan. 3 7
Net Change 1 -1
Cash & Cash Eqvt 1 0

Shareholding Pattern View Details >>

2 Qtrs 2021-09 (%) 2022-03 (%)
Promoter 71.02 71.02
Public 28.98 28.98
Depository Receipts 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00

Announcements View Details >>

No Corporate Announcement found.

Technical Scans View Details >>

Mon, 03 Oct 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Closing Above Previous High Closing Above Previous High

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,896.56 953.00 -0.1%
Divi's Laboratories Ltd. 99,171.10 3,738.70 +0.0%
Cipla Ltd. 91,534.16 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. 73,236.99 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. 63,161.01 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. 54,354.34 1,566.00 -2.3%
Zydus Lifesciences Ltd. 42,831.42 421.75 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.85 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 31.94 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 36.78 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.49 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.49 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 67.86 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.69 421.75 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.57 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 4.26 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.62 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.50 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.55 421.75 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 421.75 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 421.75 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 421.75 -0.3%

FAQ's On Walpar Nutritions Ltd.

What is Walpar Nutritions share price?

Can I buy Walpar Nutritions shares now?

What is the Market Cap of Walpar Nutritions?

What are the key metrics to analyse Walpar Nutritions?

What is the 52 Week High and Low of Walpar Nutritions?

What is the trend of Walpar Nutritions share price?